千金子制霜前后提取物对4类肠道菌影响的体外研究

目的研究并对比千金子制霜前后提取物对正常SD大鼠肠道菌群的影响。方法采用酶标比浊法,体外不同浓度千金子制霜前后提取物作用下的细菌生长曲线来研究制霜对长双歧杆菌、嗜酸乳杆菌、大肠埃希菌和粪肠球菌4种代表性肠道菌的作用,分析其对4种肠道菌生长的影响。结果千金子生品提取物和霜品提取物对4种肠道菌均有抑制作用,且随着给药浓度的增大,抑制作用增强。相同生药量下,千金子生品提取物对4种肠道菌的抑制作用均大于霜品提取物,且低剂量下会使条件致病菌粪肠球菌和大肠埃希菌的数量减少。推测千金子制霜前后均会一定程度影响肠道菌群的稳态,制霜后对4种肠道菌的影响弱于生品,与千金子制霜后泻下作用缓和的研究结果相吻合。结论从肠道微生态角度为切入点,考察千金子制霜前后提取物对肠道菌群数量和生长情况的干预作用,可初步揭示千金子制霜与肠道菌群数量和结构变化可能存在的相关性,为深入揭示千金子制霜减毒微生物学机制奠定基础。     

嗜酸乳杆菌抑菌特性的研究

目的：对从婴儿肠道中分离出来的两株嗜酸乳杆菌的抑菌特性进行研究。方法：采用MRS培养基。结果：嗜酸乳杆菌对致病性大肠埃希菌、金黄色葡萄球菌以及炭疽杆菌有明显的抑菌作用。37℃培养24h抑菌圈大小均在15mm以上。结论：该菌是肠道中的益生菌。     

乳酸、乙酸及pH对嗜酸乳杆菌和 阴道加德纳菌的生长及交互作用影响

目的探讨乳酸、乙酸及pH值变化对嗜酸乳杆菌和阴道加德纳菌的生长及交互作用影响,为探究细菌性阴道病患者治疗失败的可能原因提供依据。方法 (1)两菌经不同浓度乳酸、乙酸作用后,检测其细菌浓度变化。(2)两菌经不同pH的SBHIG肉汤单独及混合培养,检测其细菌浓度变化并涂片观察生长情况。结果乳酸、乙酸浓度1.0%~5.0%时,均可抑制两菌的生长。0.1%乳酸对阴道加德纳菌生长的抑制能力较弱,但可促进嗜酸乳杆菌的生长。肉汤培养基在pH 3.5时,几乎只有嗜酸乳杆菌能生长;pH 8.5时,生长的细菌中阴道加德纳菌占绝大多数;pH 5.5和7.0时,两菌虽然共同生长,但嗜酸乳杆菌生长明显受抑制。结论嗜酸乳杆菌与阴道加德纳菌存在交互作用,但受细菌浓度、乳酸和乙酸浓度及pH的影响。细菌性阴道病患者需多疗程疗治疗或治疗失败可能与乳杆菌累积浓度未能达到抑制阴道加德纳菌生长的要求有关。     

猪肠道乳杆菌的筛选及其生物学特性研究

目的从健康仔猪肠道中筛选到用于研制微生态制剂的优良乳杆菌株。方法本研究选用乳杆菌选择培养基LBS、MRS从健康仔猪肠道分离到67株乳杆菌,对其染色镜检、生化试验和耐酸、耐胆汁、耐高温、抑菌活性及动物安全性等生物学特性进行初步研究。结果从其中筛选到3株嗜酸乳杆菌,均能耐受pH3．0的酸度、0．8％～1．0％的牛胆盐和60℃的高温,其代谢产物对猪肠道致病性大肠埃希菌和猪沙门菌具有抑制作用,且对小白鼠无致病性。结论3株嗜酸乳杆菌符合益生菌的要求,可作为猪用益生素制剂的候选菌株。     

口炎清及其组分体外抑菌作用

目的考察口炎清及其组分对肠道部分优势菌群和条件致病菌以及口腔血链球菌和变链球菌生长的影响。方法以选择性培养基培养为基础的活菌计数法。结果 5%和10%的口炎清及其组分对葡萄球菌、大肠埃希菌均有明显的抑制作用。5%和10%的口炎清及其组分对植物来源乳酸杆菌和人来源乳酸杆菌生长抑制效果不明显,只有10%山银花流膏有一定抑制效果。10%的山银花流膏、口炎清、玄参流膏对血链球菌和变链球菌有较明显的抑制作用。5%和10%的天冬麦冬流膏对双歧杆菌的生长有促进作用。结论口炎清及其组分对于葡萄球菌、大肠埃希菌、血链球菌、变链球菌有明显的抑制作用,而对乳酸杆菌抑制作用不明显,其中某些成分还有促进双歧杆菌生长作用。     

葛根芩连汤在模拟胃肠液中对微生物生长的影响

目的探究葛根芩连汤在模拟胃肠液中对微生物生长的影响。方法在模拟胃肠液中分别加入消化液10%量的金黄色葡萄球菌、大肠埃希菌、沙门菌、产气杆菌、黑曲霉、米曲霉、青霉和汉逊德巴利酵母,然后加入生药浓度为1 g/mL的葛根芩连汤水煎液,37℃恒温培养。分别在0、1、2和4 h吸取1 mL培养液做稀释平板计数。结果体外模拟肠液中,葛根芩连汤对金黄色葡萄球菌、大肠埃希菌、沙门菌、产气杆菌、黑曲霉、米曲霉和青霉有较强的抑制作用,而对汉逊德巴利酵母的生长则为先促进后抑制,并且在2 h时对黑曲霉、米曲霉、青霉和汉逊德巴利酵母的抑制效果最显著;在模拟胃液中,葛根芩连汤对金黄色葡萄球菌、大肠埃希菌、沙门菌、黑曲霉、青霉和汉逊德巴利酵母均有一定的抑制作用,而对产气杆菌无明显影响。结论葛根芩连汤在模拟胃肠液中对金黄色葡萄球菌、大肠埃希菌、沙门菌、黑曲霉、米曲霉、青霉和汉逊德巴利酵母等均具有一定的抑制作用,在模拟肠液中对产气杆菌抑制作用明显,而在模拟胃液中对其抑制效果不明显。     

嗜酸乳杆菌产细菌素生物学特性的研究

嗜酸乳杆菌在MRS培养基中培养得到的细菌素经30、60、90、121℃处理20min后,活性几乎不变,对以金黄色葡萄球菌为代表的革兰阳性菌、大肠埃希菌为代表的革兰阴性菌有明显的抑制作用,Tricine—SDS—PAGE和不同pH值抑菌实验测定结果证明,嗜酸乳杆菌细菌素是一组低分子量,并在pH2—4时有抑菌作用的活性物质。     

凝结芽胞杆菌TBC 169株对肠道致病菌的抑菌作用

目的 研究凝结芽胞杆菌TBC 169株对大肠埃希菌、痢疾志贺菌、伤寒沙门菌、普通变形杆菌、铜绿假单胞菌和金黄色葡萄球菌的抑制作用。方法 先将大肠埃希菌、痢疾杆菌等6种菌分别进行单独培养,测定不同培养时间内的pH和活菌数,然后将凝结芽胞杆菌TBC 169株分别和致病菌进行混合培养,再测pH和活菌数,并与单独培养时的测定情况进行比较。结果 凝结芽胞杆菌TBC 169株对大肠埃希菌、痢疾志贺菌、伤寒沙门菌等6种菌均有明显的抑制作用,尤其是对伤寒沙门菌和铜绿假单胞菌的抑制作用更强。结论 凝结芽胞杆菌TBC 169株对肠道致病菌有显著的抑制作用。     

板蓝根多糖抑制致病性大肠埃希菌细胞黏附的试验研究

研究板蓝根多糖能否影响致病性大肠埃希菌对细胞的黏附。使用PK-15细胞进行了黏附试验及黏附抑制试验。在所选的4个浓度中,板蓝根多糖浓度为1.6mg/mL时,对细菌黏附细胞的抑制作用最好,黏附力由每个细胞黏附44.8个细菌降低到6.3个细菌。板蓝根多糖对致病性大肠埃希菌的细胞黏附具有抑制作用,提示该多糖具有调节肠道微生态的潜在应用价值。     

双歧杆菌试管内生物拮抗作用研究

目的 本实验从正常青少年体内分离出1株双歧杆菌,通过试管内研究双歧杆菌对大肠埃希菌和粪肠球菌的生物拮抗作用.为双歧杆菌临床应用及食品开发提供一定的基础理论依据和广阔的市场前景.方法 本项研究以从佳木斯大学健康学生体内分离出1株双歧杆菌为试材,将大肠埃希菌、粪肠球菌接种于PYG液体培养基中,37℃厌氧培养48 h,将菌液浓度利用分光光度计法调到2麦氏.将大肠埃希菌对照组分为10支,分离的双歧杆菌+大肠埃希菌组10支,分离的双歧杆菌对照组10支,分离的双歧杆菌+粪肠球菌组10支,粪肠球菌对照组10支,将以上50个试管全部置于厌氧培养箱内37℃培养48 h,将培养好的大肠埃希菌和粪肠球菌进行梯度稀释,然后用微量移液器吸取标本于每个培养基上滴3滴,每滴滴上由高稀释度向低稀释度,液体量为10 μL的菌液.晾干滴种好的培养基于适宜条件进行培养并选出适合菌落生长的稀释度,计算同一稀释度平均菌落数(x).结果 双歧杆菌12 h时对大肠埃希菌生长无显著性,在24h时检测不到大肠埃希菌的存在.12和24h时粪肠球菌与双歧杆菌混合组与粪肠球菌对照组相比,差异均无统计学意义(P＞0.05).结论 体外对照实验研究该双歧杆菌对大肠埃希菌和粪肠球菌的生物拮抗作用,此株双歧杆菌只对大肠埃希菌有抑制作用,而对粪肠球菌无抑制作用,机制需要深入研究.     

细菌对肉鸡肠粘液的粘附作用

研究两歧双歧杆菌、嗜酸乳杆菌、禽大肠杆菌O78、大肠杆菌 ATCC 25922、鸡白痢沙门氏菌和鼠伤寒沙门氏菌与肉鸡不同部位肠粘液糖蛋白的粘附性能,探讨两歧双歧杆菌和嗜酸乳杆菌对所试病原菌的抗粘附作用。结果表明：在不同的肠道部位,两歧双歧杆菌、嗜酸乳杆菌、鸡白痢沙门氏菌和鼠伤寒沙门氏菌与肠粘液糖蛋白均有不同的粘附作用,而禽大肠杆菌O78、大肠杆菌 ATCC 25922在各肠段粘液上的粘附性能则相近;在相同的肠道部位,所试益生菌的粘附能力大于病原菌;两歧双歧杆菌和嗜酸乳杆菌对所试病原菌的粘附有不同的阻断作用,同时二者有时还存在互补抗粘附作用。     

Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells

The intestinal epithelial cell (IEC) layer of the intestinal tract makes direct contact with a number of microbiota communities, including bacteria known to have deleterious health effects. IECs possess innate protective strategies against pathogenic challenge, which primarily involve the formation of a physicochemical barrier. Intestinal tract mucins are principal components of the mucus layer on epithelial surfaces, and perform a protective function against microbial damage. However, little is currently known regarding the interactions between probiotics/pathogens and epithelial cell mucins. The principal objective of this study was to determine the effects of Lactobacillus on the upregulation of MUC2 mucin and the subsequent inhibition of E. coli O157:H7 attachment to epithelial cells. In the current study, the attachment of E. coli O157:H7 to HT-29 intestinal epithelial cells was inhibited significantly by L. acidophilus A4 and its cell extracts. It is also important to note that the expression of MUC2 mucin was increased as the result of the addition of L. acidophilus A4 cell extracts (10.0 mg/ml), which also induced a significant reduction in the degree to which E. coli O157:H7 attached to epithelial cells. In addition, the mRNA levels of IL-8, IL-1beta, and TNF-alpha in HT-29 cells were significantly induced by treatment with L. acidophilus A4 extracts. These results indicate that MUC2 mucin and cytokines are important regulatory factors in the immune systems of the gut, and that selected lactobacilli may be able to induce the upregulation of MUC2 mucin and specific cytokines, thereby inhibiting the attachment of E. coli O157:H7.     

莳萝蒿精油成分分析及抑菌活性机理探究

为了确定莳萝蒿精油的化学成分,并探究其抑菌活性及抑菌机理。该研究采用水蒸气蒸馏法提取莳萝蒿精油,并通过气相色谱-质谱联用法测定其化学成分。采用抑菌圈法、二倍稀释法和生长曲线法测定精油的抑菌活性,采用电导率法和扫描电镜法探究精油的抑菌机理。结果表明:(1)莳萝蒿精油的主要化学成分包括醇类(47.12%)和萜烯类(19.90%),在所有成分中桉油精(12.39%)含量最高,其次为松油醇(8.70%)。(2)精油对金黄色葡萄球菌和大肠杆菌的抑菌圈直径分别为(22.57±1.68)mm和(15.36±0.71)mm。(3)精油对金黄色葡萄球菌和大肠杆菌的最小抑菌浓度分别为3.25和7.5μL/mL,最小杀菌浓度分别为7.5和15μL/mL。(4)当精油浓度为1.625和3.25μL/mL时,其分别能够延缓金黄色葡萄球菌和大肠杆菌的生长;当精油浓度为3.25和7.5μL/mL时,其能够完全抑制金黄色葡萄球菌的生长;当精油浓度为7.5和15μL/mL时,其能够完全抑制大肠杆菌的生长。(5)经精油处理之后的细菌,其相对电导率明显增大,且随精油浓度的增加而增大,同时其细胞膜发生了萎缩和破裂的现象。研究发现,莳萝蒿精油富含醇类和萜烯类等多种活性物质,对金黄色葡萄球菌和大肠杆菌具有良好的抑菌活性,且莳萝蒿精油能够改变细胞的膜结构,导致细菌中的内溶物发生泄漏,从而抑制细菌生长。     

Effects of Rosa rugosa petals on intestinal bacteria

The effects of pulverized petal of Rosa rugosa on the growth of 10 species of intestinal and pathogenic bacteria were investigated. Growth of bifidobacteria and lactobacilli was not affected by the addition of the petal in plate cultivation. However, the growth of Bacteroides vulgatus, Escherichia coli, Staphylococcus aureus, and Bacillus cereus was completely inhibited by the addition of 0.1, 0.5, 0.1, and 0.05% (w/v) of the petal respectively. In liquid cultivation, the addition of the petal (0.5%) stimulated the growth of Bifidobacterium breve and slightly inhibited the growth of Lactobacillus salivarius. But the growth of E. coli, S. aureus, B. cereus, and Salmonella sp. was inhibited by nearly 50%. Hydrolyzable tannins isolated from R. rugosa, rugosin D, and tellimagradin II showed antibacterial activities against E. coli, S. aureus, B. cereus, and Salmonella sp., but little or no effect against Bif. breve and L. salivarius. R. rugosa petal showed selective antibacterial activities against intestinal and pathogenic bacteria, and the selectivity resembled that of prebiotics such as oligosaccharides and dietary fiber. Hydrolyzable tannins in R. rugosa, such as rugosin D and tellimagradin II, must be active constituents.     

Characterization of vaginal lactobacilli coaggregation ability with Escherichia coli

The coaggregation abilities of probiotic strains might enable it to form a barrier that prevents colonization by pathogenic bacteria. In the present study, the characterization of the coaggregation ability of 19 vaginal lactobacilli was studied. Coaggregation ability of all lactobacilli with Escherichia coli ATCC 11229 was positive. Only the highest coaggregation percentage of Lactobacillus acidophilus S1 was obtained with E. coli ATCC 11229 under both aerobic (71%) and anaerobic conditions (62%). The coaggregation abilities of strains occurred higher at acidic pH than at basic pH values. Moreover, the coaggregation abilities of tested strains against E. coli decreased after heat treatment (70 or 85 °C). Also, the relationship between hydrophobicity and coaggregation of strains was found to be significant. The effect of sonication, some enzymes (lipase and pepsin) and sodium periodate on coaggregation ability of L. acidophilus S1, which is one of the highest potentials on coaggregation ability, was investigated. Sodium periodate did not have a significant effect on coaggregation ability of L. acidophilus S1. The sonicated cell showed lower coaggregation than the control, the supernatant fluid of this sonicated cells showed similar coaggregation ability to the control. Coaggregation abilities of bacteriotherapeutic lactobacilli with pathogenic bacteria can be used for preliminary screening in order to identify potentially probiotic bacteria suitable for human use against urogenital tract infections.     

Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli

During routine quality control testing of diagnostic methods for Shiga toxin-producing Escherichia coli (STEC) using stool samples spiked with STEC, it was observed that the Shiga toxin could not be detected in 32 out of 82 samples tested. Strains of E. coli isolated from such stool samples were shown to be responsible for this inhibition. One particular isolate, named E. coli 1307, was intensively studied because of its highly effective inhibitory effect; this strain significantly reduced growth and Shiga toxin levels in coculture of several STEC strains regardless of serovar or Shiga toxin type. The probiotic E. coli Nissle 1917 inhibited growth and reduced Shiga toxin levels in STEC cultures to an extent similar to E. coli 1307, but commensal E. coli strains and several other known probiotic bacteria (enterococci, Bacillus sp., Lactobacillus acidophilus ) showed no, or only small, inhibitory effects. Escherichia coli 1307 lacks obvious fitness factors, such as aerobactin, yersiniabactin, microcins and a polysaccharide capsule, that are considered to promote the growth of pathogenic bacteria. We therefore propose strain E. coli 1307 as a candidate probiotic for use in the prevention and treatment of infections caused by STEC.     

Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus

Diarrheagenic Escherichia coli (ETEC) bearing CFA/I or CFA/II adhesive factors specifically adhere onto the brush border of the polarized epithelial human intestinal Caco-2 cells in culture. Heat-killed Lactobacillus acidophilus strain LB, that adheres onto Caco-2 cells, inhibits diarrheagenic Escherichia coli adhesion in a concentration-dependent manner. Since the L. acidophilus does not express ETEC-CFA adhesive factors, it can be postulated that the heat-killed L. acidophilus LB cells inhibit diarrheagenic E. coli attachment by steric hindrance of the human enterocytic ETEC receptors.